BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1581466)

  • 1. Cell-mediated immunity to orbital tissue antigens in thyroid-associated ophthalmopathy determined using the leukocyte procoagulant activity assay.
    Cohen M; Salvi M; Miller A; Bernard N; Wall JR
    Autoimmunity; 1992; 11(4):225-31. PubMed ID: 1581466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
    Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
    Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.
    Kiljanski J; Stolarski C; Barsouk A; Nebes V; Wall JR
    J Endocrinol Invest; 1996 May; 19(5):284-92. PubMed ID: 8796336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirm their significance in thyroid-associated ophthalmopathy.
    Barsouk A; Wengrowicz S; Scalise D; Stolarski C; Nebes V; Sato M; Wall JR
    Thyroid; 1995 Jun; 5(3):195-200. PubMed ID: 7580267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature of 64 kDa eye muscle and thyroid membrane proteins and their significance in thyroid-associated ophthalmopathy--an hypothesis.
    Boucher A; Bernard N; Zhang ZG; Rodien P; Salvi M; Wall JR
    Autoimmunity; 1993; 16(2):79-82. PubMed ID: 8180320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
    Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
    Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting.
    Bernard NF; Ertug F; Teboul N; Zhang ZG; Salvi M; Wall JR
    Autoimmunity; 1991; 10(1):57-63. PubMed ID: 1742423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to orbital antigens in thyroid-associated ophthalmopathy.
    Arnold K; Tandon N; McIntosh RS; Elisei R; Ludgate M; Weetman AP
    Clin Exp Immunol; 1994 May; 96(2):329-34. PubMed ID: 8187342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy.
    Dillon J; Zhang ZG; Hiromatsu N; Bernard M; Salvi M; Wall JR
    Autoimmunity; 1989; 5(1-2):125-32. PubMed ID: 2519012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted tissue reactivity of autoantibodies to a 64-kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
    Zhang ZG; Salvi M; Miller A; Bernard N; Arthurs B; Wall JR
    Clin Immunol Immunopathol; 1992 Feb; 62(2):183-9. PubMed ID: 1730156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot.
    Hiromatsu Y; Sato M; Tanaka K; Shoji S; Nonaka K; Chinami M; Fukazawa H
    Autoimmunity; 1992; 14(1):9-16. PubMed ID: 1299352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
    Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
    Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
    Gunji K; Kubota S; Stolarski C; Wengrowicz S; Kennerdell JS; Wall JR
    Autoimmunity; 1999; 29(1):1-9. PubMed ID: 10052680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.